Creative Medical Technology Holdings, Inc.
CELZ
$2.14
$0.052.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | -- | -- | -- | -83.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | -- | -- | -- | -83.87% |
| Cost of Revenue | 0.00% | -- | -- | -- | -78.95% |
| Gross Profit | 0.00% | -- | -- | -- | -86.05% |
| SG&A Expenses | -0.40% | -6.10% | -21.34% | -12.91% | 55.48% |
| Depreciation & Amortization | -11.37% | 27.39% | 27.39% | 27.39% | 10.87% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.42% | -28.37% | 37.02% | 0.90% | -71.81% |
| Operating Income | -6.43% | 28.09% | -36.35% | -0.90% | 71.78% |
| Income Before Tax | -10.46% | 28.47% | -41.34% | 0.99% | 72.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.46% | 28.47% | -41.34% | 0.99% | 72.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.46% | 28.47% | -41.34% | 0.99% | 72.99% |
| EBIT | -6.43% | 28.09% | -36.35% | -0.90% | 71.78% |
| EBITDA | -6.69% | 28.93% | -36.53% | -0.36% | 72.08% |
| EPS Basic | 10.39% | 26.44% | -41.81% | 1.95% | 72.42% |
| Normalized Basic EPS | 10.39% | 26.45% | -41.82% | 1.95% | 72.42% |
| EPS Diluted | 10.39% | 26.44% | -41.81% | 1.95% | 72.42% |
| Normalized Diluted EPS | 10.39% | 26.45% | -41.82% | 1.95% | 72.42% |
| Average Basic Shares Outstanding | 23.26% | -2.73% | -0.33% | 0.98% | -2.09% |
| Average Diluted Shares Outstanding | 23.26% | -2.73% | -0.33% | 0.98% | -2.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |